Generex Biotechnology Corp. (fka GNBTQ)

[WeeZuhl]

NuGenerex Diagnostics using peptides to develop a rapid test for 2019-nCOV in respiratory and blood samples using its proprietary NGDx Express II rapid diagnostic technology

2/6/20:
https://storage.googleapis.com/wzukusers/user-26831283/documents/5e3badc563bb2iYHedXv/PR_Generex_Coronavirus_Projects_2_6_2020.pdf




Lord knows I haven't kept up with all of the PR coming out of this company, but I try to pay special attention for updates on the COVID-19 diagnostic test. Clicking the COVID link on the main page of the website does not even mention it. Have I missed something since Feb 6? All the updates seem to be about the peptide vaccine from NGIO, which has great potential, but what about the diagnostic test? This is right in the NGDx wheelhouse. Developing rapid, reliable diagnostic tests for emerging infectious diseases is kind of their thing. My primary care office is able to offer COVID testing for our patients as of today, but I don't know of any other office in the area that has COVID testing, including the big hospital-owned practices. We received 10 test kits today, which is an accomplishment, but not the important part. The test kit is literally a cotton swab, sterile tube, and a bio-hazard bag. The tech is in the lab. The real trick is having someone who will come pick up the test kit and process the swab, which we do, but I'm afraid I can't reveal how the trick is being performed. We'll just say a big bird took us under their wing. The simple ability to offer a COVID test to our patients is a great relief, but we only cover a few hundred people. It is extremely problematic that these tests are not more widely available, especially as we prepare to reopen society. We are encouraging our patients to stay low for the foreseeable future. A strong test from NGDx would be a huge benefit to humanity (and might even make a few bucks).